ESSA Pharma

ESSA Pharma: Developing novel therapies for the treatment of prostate cancer targeting the N-terminal domain of the androgen receptor. ESSA’s lead candidate, EPI-7386, is a first-in-class, highly-selective, oral, small molecule N-terminal domain inhibitor currently being evaluated in a Ph 1 trial as a monotherapy in patients with castration-resistant prostate cancer (CRPC) and in a Phase 1/2 trial in combination with Astellas' and Pfizer’s antiandrogen enzalutamide in patients with metastatic CRPC.
Based in...
US - Pacific
Clinical Stage
Phase l or ll, Pre-Clinical Stage
Disease Space
Men's Health, Oncology
Public, USA
Market Cap
400 Oyster Point Blvd.
South San Francisco, CA 94080
United States

Company Participants at Solebury 1x1 Management Access Event 2023

  • David Parkinson, President/CEO

Upcoming Company Event Participation

Top 10 Holders of ESSA Pharma Inc

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
BVF Partners LP 19.86 8,748,629 28.00 Stakes 7/11/22
BVF, Inc. 19.85 8,748,629 28.00 13F 9/30/22
Bellevue Asset Management AG 17.88 7,879,583 25.21 Stakes 10/27/22
PFM Health Sciences LP 8.72 3,844,332 12.30 Stakes 10/31/22
Avidity Partners Management LP 8.51 3,750,000 12.00 Stakes 10/26/22
Soleus Capital Management LP (Investment Management) 8.02 3,525,457 11.28 Stakes 12/31/21
Soleus Capital Management LP 5.99 2,640,539 8.45 13F 9/30/22
Morgan Stanley Capital Services LLC 4.76 2,099,967 6.72 13F 9/30/22
Eventide Asset Management LLC 3.54 1,561,251 5.00 13F 9/30/22
RTW Investments LP 2.98 1,311,294 4.20 13F 9/30/22
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2022 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.